Latest news with #CL
Yahoo
6 days ago
- Business
- Yahoo
How Reliable Is Colgate-Palmolive Company (CL) for Long-Term Dividend Income?
Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company's oral care products. The company has been rewarding shareholders with growing dividends for the past 62 consecutive years, which places it in an elite group of Dividend Kings. The stock supports a dividend yield of 2.28%, as of July 10. In the first quarter of 2025, Colgate-Palmolive Company (NYSE:CL) reported strong earnings, with its revenue coming in at $4.9 billion, which beat estimates by $47.8 million. The company's GAAP gross profit margin and Base Business gross profit margin both rose by 80 basis points, reaching 60.8%. It maintained its leading position in the toothpaste market, holding a global share of 40.9% year to date. The company also continued to lead the manual toothbrush segment with a global market share of 31.9% over the same period. Colgate-Palmolive Company (NYSE:CL) is a consumer goods company offering a range of products across oral care, personal care, household, and pet care categories. The stock has surged by nearly 6% in the past six months. While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
The Mainichi
12-07-2025
- Sport
- The Mainichi
Baseball: Swallows prevail to end Tigers' 11-game winning run
NISHINOMIYA (Kyodo) -- The Yakult Swallows held on to beat the Hanshin Tigers 6-3 on Friday, ending the Central League-leading club's 11-game winning streak. The Swallows, bottom of the CL, scored all their runs in the second inning at Koshien Stadium, where their six straight singles with two outs scored two runs before Soma Uchiyama slugged a grand slam to left off Shoki Murakami (8-3), who was taken off after the inning. Swallows starter Peter Lambert (2-7), who plated their first run, allowed four singles and a walk to open the fourth as the Tigers scored two runs before getting three straight outs to end the inning. He issued three straight walks to start the fifth, and Yusuke Oyama drove in his second run of the game with a sacrifice fly. But the former Colorado Rockies right-hander retired the next two batters and earned the win after giving up six hits and five walks over five innings. In other action, Ryuhei Sotani (8-3) threw eight shutout innings as the Orix Buffaloes blanked the Nippon Ham Fighters 6-0 to end the Pacific League-leading club's five-game winning run.
Yahoo
10-07-2025
- Business
- Yahoo
Why Byrna (BYRN) Shares Are Trading Lower Today
Shares of non-lethal weapons company Byrna (NASDAQ:BYRN) fell 22.3% in the morning session after the company reported its fiscal second-quarter 2025 financial results. Although Byrna announced a record-breaking quarter with a 41% year-over-year revenue increase to $28.5 million, the stock's dip suggests a "sell the news" reaction from investors. The strong sales were driven by the launch of the new Byrna Compact Launcher (CL) and a 106% surge in dealer sales, bolstered by an expanding partnership with Sportsman's Warehouse. The company's adjusted earnings per share of $0.10 beat analyst expectations of $0.08. However, the positive results may have already been priced into the stock, which has seen a significant run-up of over 80% in the past three months. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Byrna? Access our full analysis report here, it's free. Byrna's shares are extremely volatile and have had 73 moves greater than 5% over the last year. But moves this big are rare even for Byrna and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote about was 1 day ago when the stock gained 4.1% on the news that an analyst at Roth Capital raised their price target on the shares. The firm boosted its target to $37.00 from $33.00 while maintaining a "buy" rating on the stock. This new price target suggests a potential upside of nearly 13% from the previous closing price. The move comes ahead of the non-lethal defense technology company's fiscal second-quarter 2025 earnings report, which is scheduled for release on Thursday, July 10. Investors are anticipating strong results, with analysts forecasting revenue to grow over 40% year-over-year to around $28.5 million. This optimism follows the company's preliminary announcement in early June of record second-quarter revenues, driven by high demand for its new Byrna Compact Launcher (CL). Byrna is down 9.9% since the beginning of the year, and at $25.51 per share, it is trading 25.4% below its 52-week high of $34.19 from February 2025. Investors who bought $1,000 worth of Byrna's shares 5 years ago would now be looking at an investment worth $2,008. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-07-2025
- Business
- Yahoo
Byrna (BYRN) Stock Trades Up, Here Is Why
Shares of non-lethal weapons company Byrna (NASDAQ:BYRN) jumped 4.1% in the pre market session after an analyst at Roth Capital raised their price target on the shares. The firm boosted its target to $37.00 from $33.00 while maintaining a "buy" rating on the stock. This new price target suggests a potential upside of nearly 13% from the previous closing price. The move comes ahead of the non-lethal defense technology company's fiscal second-quarter 2025 earnings report, which is scheduled for release on Thursday, July 10. Investors are anticipating strong results, with analysts forecasting revenue to grow over 40% year-over-year to around $28.5 million. This optimism follows the company's preliminary announcement in early June of record second-quarter revenues, driven by high demand for its new Byrna Compact Launcher (CL). After the initial pop the shares cooled down to $32.00, down 0.6% from previous close. Is now the time to buy Byrna? Access our full analysis report here, it's free. Byrna's shares are extremely volatile and have had 74 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Byrna is up 13% since the beginning of the year, and at $32.00 per share, it is trading close to its 52-week high of $34.19 from February 2025. Investors who bought $1,000 worth of Byrna's shares 5 years ago would now be looking at an investment worth $2,520. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-07-2025
- Business
- Yahoo
Colgate-Palmolive's Quarterly Earnings Preview: What You Need to Know
Headquartered in New York, Colgate-Palmolive Company (CL) is a premier manufacturer and seller of consumer products in the United States and internationally. With a market cap of $76.2 billion, the company operates through two segments: Oral, Personal and Home Care; and Pet Nutrition and offers products under famous brands including Colgate, Palmolive, Darlie, elmex, hello, meridol, and Sorriso. The consumer goods giant is expected to report its Q2 earnings on Friday, Aug. 1, before the market opens. Ahead of the event, analysts expect CL to report an EPS of $0.88 per share, down 3.3% from $0.91 per share reported in the year-ago quarter. It has exceeded analysts' earnings estimates in all of the past four quarters, which is admirable. This Analyst Just Raised His Broadcom Stock Price Target by 70%. Should You Buy AVGO Now? Why Alibaba Stock Looks Like a Screaming Buy After Falling 27% From Its 2025 Highs 'Superintelligence' Takes Meta Platforms to Record Highs. Should You Buy META Stock Here? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For fiscal 2025, analysts expect CL to report an adjusted EPS of $3.65, up 1.4% from $3.60 in fiscal 2024. In fiscal 2026, its adjusted EPS is expected to grow 7.4% year-over-year to $3.92. Over the past year, CL shares have declined 3.8%, underperforming the S&P 500 Index's ($SPX) 11.9% rally and the Consumer Staples Select Sector SPDR Fund's (XLP) 6.1% return over the same time frame. On Apr. 25, Colgate-Palmolive shares edged up 1.3% following the release of its Q1 earnings report. While net sales declined 3% year-over-year to $4.9 billion, they still came in 1% above consensus estimates. Despite sluggish category growth in several markets, the company saw an improvement in organic sales, highlighting the resilience of its brand portfolio and the successful execution of its strategic initiatives. Adjusted EPS rose 5.8% year-over-year to $0.91, surpassing Wall Street expectations. The consensus opinion on CL stock is moderately optimistic, with an overall 'Moderate Buy' rating. Out of the 20 analysts covering the stock, 10 recommend a 'Strong Buy,' two suggest a 'Moderate Buy,' six suggest a 'Hold' rating, and the remaining two suggest a 'Strong Sell' rating. Its mean price target of $98.50 indicates a 5.5% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
